 | Up a level |
Journal Article
Heidenreich, S., Zabelina, T., van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schwerdtfeger, R., Beelen, D., Tischer, J., Nagler, A., Zachee, P., Scheid, C., de Witte, T., Robin, M. and Kroger, N. (2015). Allogeneic stem cell transplantation for MDS patients more than 70 years of age. A report of MDS subcommittee of CMWP of EBMT. Bone Marrow Transplant., 50. S. S305 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Heidenreich, S., Zabelina, T., van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schwerdtfeger, R., Beelen, D., Tischer, J., Nagler, A., Zachee, P., Scheid, C., de Witte, T., Robin, M. and Kroger, N. (2015). Allogeneic stem cell transplantation for MDS patients more than 70 years of age. A report of MDS subcommittee of CMWP of EBMT. Bone Marrow Transplant., 50. S. S305 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Koenecke, C., Goehring, G., de Wreede, L., van Biezen, A., Scheid, C., Volin, L., Maertens, J., Finke, J., Schaap, N. P. M., Robin, M., Passweg, J., Cornelissen, J., Beelen, D., Heuser, M., de Witte, T. and Kroeger, N. (2014). IMPACT OF CYTOGENETIC USING THE IPSS REVISED CYTOGENETIC CLASSIFICATION ON OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR MDS OR AML EVOLVING FROM MDS: A RETROSPECTIVE MULTICENTER STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF THE EBMT. Bone Marrow Transplant., 49. S. S8 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Kroeger, N., Brand, R., Niederwieser, D., Platzbecker, U., Huebel, K., Weber, T., Robin, M., Stelljes, M., Afanasiev, B., Heim, D., Deliliers, G. Lambertenghi, Onida, F., Dreger, P., Pini, M., Guidi, S., Volin, L., Gramatzki, M., Bethge, W., Poire, X., Kobbe, G., van Os, M., Iacobelli, S. and de Witte, T. (2015). RIC vs. MAC followed by allogeneic stem cell transplantation for patients with MDS or secondary AML: A prospective, randomized phase III study of the CMWP of the EBMT (RICMAC-Trial). Bone Marrow Transplant., 50. S. S5 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Kroeger, N., Brand, R., Niederwieser, D., Platzbecker, U., Huebel, K., Weber, T., Robin, M., Stelljes, M., Afanasiev, B., Heim, D., Deliliers, G. Lambertenghi, Onida, F., Dreger, P., Pini, M., Guidi, S., Volin, L., Gramatzki, M., Bethge, W., Poire, X., Kobbe, G., van Os, M., Iacobelli, S. and de Witte, T. (2015). RIC vs. MAC followed by allogeneic stem cell transplantation for patients with MDS or secondary AML: A prospective, randomized phase III study of the CMWP of the EBMT (RICMAC-Trial). Bone Marrow Transplant., 50. S. S5 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Scheid, C., de Wreede, L., van Biezen, A., Goehring, G., Koenecke, C., Volin, L., Maertens, J., Finke, J., Schaap, N., Socie, G., Passweg, J., Cornelissen, J., Beelen, D., de Witte, T. and Kroeger, N. (2014). THE REVISED IPSS (IPSS-R) AT TRANSPLANT PREDICTS OVERALL AND RELAPSE-FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN MDS/SAML: A RETROSPECTIVE ANALYSIS OF THE EBMT CHRONIC MALIGNANCIES WORKING PARTY. Bone Marrow Transplant., 49. S. S93 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365